| Dr Anne Greist, MD | |
|
8326 Naab Rd, Indianapolis, IN 46260-1920 | |
| (317) 871-0000 | |
| (317) 871-0010 |
| Full Name | Dr Anne Greist |
|---|---|
| Gender | Female |
| Speciality | Hematology/oncology |
| Experience | 47 Years |
| Location | 8326 Naab Rd, Indianapolis, Indiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063477073 | NPI | - | NPPES |
| 100236530 | Medicaid | IN | |
| 830005880 | Other | IN | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 01033362A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Indiana University Health | Indianapolis, IN | Hospital |
| Ascension St Vincent Hospital | Indianapolis, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Medical Diagnostic Associates Inc | 3375446347 | 279 |
| Indiana Hemophilia And Thrombosis Center, Inc. | 4183605306 | 23 |
News Archive
The anti-inflammatory drug indomethacin could hold promise as a treatment for Alzheimer's disease, says a Saint Louis University doctor and researcher.
Members of the media are invited to attend a press availability period at noon on Friday, December 18, 2009 that will follow a scientific meeting evaluating the safety of soy infant formula. An independent panel of 14 scientists will evaluate the most current research on soy infant formula to determine whether exposure to soy infant formula is a risk to human development.
HHS Secretary Kathleen Sebelius will introduce www.HealthCare.gov, a powerful new tool for consumers. The Secretary and Todd Park, Chief Technology Officer for HHS, will roll out the new site, called for in the Affordable Care Act, demonstrate some of its important features and answer questions from the media.
One of the human body's protective mechanisms initiated by the TRAIL protein is massively altered in prostate cancer cells - yet the same protein seems to improve the survival prospects of patients. These outstanding results of a cooperative venture between the Clinical Program on Urological Tumours at the Medical University of Vienna and Harvard Medical School, USA, have just been published. They show that the TRAIL protein opens up the prospect to a more accurate prediction of the disease's course, as well as the opportunity to identify a new intervention point for innovative therapies in advanced prostate cancer.
European Union member countries on Thursday expressed concerns about U.S. plans that could require visitors to provide personal health details, including information about their HIV/AIDS status, before they enter the country, the AP/International Herald Tribune reports.
› Verified 2 days ago
| Entity Name | University Medical Diagnostic Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861441537 PECOS PAC ID: 3375446347 Enrollment ID: O20040202000510 |
News Archive
The anti-inflammatory drug indomethacin could hold promise as a treatment for Alzheimer's disease, says a Saint Louis University doctor and researcher.
Members of the media are invited to attend a press availability period at noon on Friday, December 18, 2009 that will follow a scientific meeting evaluating the safety of soy infant formula. An independent panel of 14 scientists will evaluate the most current research on soy infant formula to determine whether exposure to soy infant formula is a risk to human development.
HHS Secretary Kathleen Sebelius will introduce www.HealthCare.gov, a powerful new tool for consumers. The Secretary and Todd Park, Chief Technology Officer for HHS, will roll out the new site, called for in the Affordable Care Act, demonstrate some of its important features and answer questions from the media.
One of the human body's protective mechanisms initiated by the TRAIL protein is massively altered in prostate cancer cells - yet the same protein seems to improve the survival prospects of patients. These outstanding results of a cooperative venture between the Clinical Program on Urological Tumours at the Medical University of Vienna and Harvard Medical School, USA, have just been published. They show that the TRAIL protein opens up the prospect to a more accurate prediction of the disease's course, as well as the opportunity to identify a new intervention point for innovative therapies in advanced prostate cancer.
European Union member countries on Thursday expressed concerns about U.S. plans that could require visitors to provide personal health details, including information about their HIV/AIDS status, before they enter the country, the AP/International Herald Tribune reports.
› Verified 2 days ago
| Entity Name | Indiana Hemophilia & Thrombosis Center, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659364800 PECOS PAC ID: 4183605306 Enrollment ID: O20040525000925 |
News Archive
The anti-inflammatory drug indomethacin could hold promise as a treatment for Alzheimer's disease, says a Saint Louis University doctor and researcher.
Members of the media are invited to attend a press availability period at noon on Friday, December 18, 2009 that will follow a scientific meeting evaluating the safety of soy infant formula. An independent panel of 14 scientists will evaluate the most current research on soy infant formula to determine whether exposure to soy infant formula is a risk to human development.
HHS Secretary Kathleen Sebelius will introduce www.HealthCare.gov, a powerful new tool for consumers. The Secretary and Todd Park, Chief Technology Officer for HHS, will roll out the new site, called for in the Affordable Care Act, demonstrate some of its important features and answer questions from the media.
One of the human body's protective mechanisms initiated by the TRAIL protein is massively altered in prostate cancer cells - yet the same protein seems to improve the survival prospects of patients. These outstanding results of a cooperative venture between the Clinical Program on Urological Tumours at the Medical University of Vienna and Harvard Medical School, USA, have just been published. They show that the TRAIL protein opens up the prospect to a more accurate prediction of the disease's course, as well as the opportunity to identify a new intervention point for innovative therapies in advanced prostate cancer.
European Union member countries on Thursday expressed concerns about U.S. plans that could require visitors to provide personal health details, including information about their HIV/AIDS status, before they enter the country, the AP/International Herald Tribune reports.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Anne Greist, MD 8326 Naab Rd, Indianapolis, IN 46260-1920 Ph: (317) 871-0000 | Dr Anne Greist, MD 8326 Naab Rd, Indianapolis, IN 46260-1920 Ph: (317) 871-0000 |
News Archive
The anti-inflammatory drug indomethacin could hold promise as a treatment for Alzheimer's disease, says a Saint Louis University doctor and researcher.
Members of the media are invited to attend a press availability period at noon on Friday, December 18, 2009 that will follow a scientific meeting evaluating the safety of soy infant formula. An independent panel of 14 scientists will evaluate the most current research on soy infant formula to determine whether exposure to soy infant formula is a risk to human development.
HHS Secretary Kathleen Sebelius will introduce www.HealthCare.gov, a powerful new tool for consumers. The Secretary and Todd Park, Chief Technology Officer for HHS, will roll out the new site, called for in the Affordable Care Act, demonstrate some of its important features and answer questions from the media.
One of the human body's protective mechanisms initiated by the TRAIL protein is massively altered in prostate cancer cells - yet the same protein seems to improve the survival prospects of patients. These outstanding results of a cooperative venture between the Clinical Program on Urological Tumours at the Medical University of Vienna and Harvard Medical School, USA, have just been published. They show that the TRAIL protein opens up the prospect to a more accurate prediction of the disease's course, as well as the opportunity to identify a new intervention point for innovative therapies in advanced prostate cancer.
European Union member countries on Thursday expressed concerns about U.S. plans that could require visitors to provide personal health details, including information about their HIV/AIDS status, before they enter the country, the AP/International Herald Tribune reports.
› Verified 2 days ago
Irene A Carrothers, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1701 Senate Blvd, Indianapolis, IN 46202 Phone: 317-963-8776 Fax: 317-963-5285 | |
Liam P Howley, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 1001 West 10th St Opw-m200, Indiana University Department Of Medicine, Indianapolis, IN 46202 Phone: 317-630-6560 | |
Cristina Nancy Perez Chumbiauca, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 550 University Blvd, Indianapolis, IN 46202 Phone: 317-944-5000 | |
Dr. Andrew Jonathen Ortega, DO Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 702 Rotary Cir, Indianapolis, IN 46202 Phone: 317-278-4427 | |
Lawrence John Born, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 8424 Naab Rd, #3-j, Indianapolis, IN 46260 Phone: 317-872-7396 Fax: 317-879-8328 | |
Brian T Robinson, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1001 W 10th St, Indianapolis, IN 46202 Phone: 317-630-7979 Fax: 317-630-2668 | |
Steven T Hugenberg, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 550 University Blvd, Indianapolis, IN 46202 Phone: 317-944-8660 |